ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO881

Association of Pre-ESRD Serum Bicarbonate with Post-ESRD Mortality among Incident Dialysis Patients: A Transition of Care in CKD Study

Session Information

Category: Dialysis

  • 607 Dialysis: Epidemiology, Outcomes, Clinical Trials - Non-Cardiovascular

Authors

  • Obi, Yoshitsugu, UC Irvine, Orange, California, United States
  • Catabay, Christina J., UC Irvine, Orange, California, United States
  • Soohoo, Melissa, UC Irvine, Orange, California, United States
  • Park, Christina, UC Irvine, Orange, California, United States
  • Streja, Elani, UC Irvine, Orange, California, United States
  • Kovesdy, Csaba P., University of Tennessee Health Science Center, Memphis, Tennessee, United States
  • Kalantar-Zadeh, Kamyar, UC Irvine, Orange, California, United States
Background

Serum bicarbonate (S-CO2) levels decline as CKD progresses and rise after dialysis initiation. While the current clinical guidelines suggest maintaining S-CO2 > 22 mEq/L among pre-ESRD patients with CKD, there are scarce data on the impact of pre-ESRD S-CO2 levels on post-ESRD mortality.

Methods

Among 32,655 US veterans who transitioned to dialysis between October 2007 and March 2014, we calculated 6-month averaged levels and annual decline rate of S-CO2 during the last pre-ESRD period, and then estimated their risk for all-cause mortality with Cox regression adjusting for demographics, comorbidities, BMI, and eGFR.

Results

Mean baseline concentrations and rates of decline of S-CO2 were 23±4 mEq/L and -1.8±2.4 mEq/L/year, respectively. Higher S-CO2 >20 mEq/L showed higher adjusted mortality risk while there was no clear trend in the lower range. Compared to S-CO2 of 22 mEq/L, adjusted HRs (95%CIs) were 0.96 (0.94–0.97), 1.09 (1.07–1.12), and 1.22 (1.18–1.27) at 20, 24, and 26 mEq/L, respectively. Consistent associations were observed irrespective of sodium bicarbonate use. There was a U-shaped association between the rate of decline in S-CO2 and mortality with the lowest risk being approximately -2.0 mEq/L/year. Both faster decline and rise in S-CO2 were more strongly associated with mortality among sodium bicarbonate users vs. non-users.

Conclusion

Pre-ESRD S-CO2 levels above 20 mEq/L exhibited an incrementaly higher post-ESRD mortality risk. Further studies are needed to elucidate whether high S-CO2 is a surrogate of low protein intake, comorbid states, or other mechanisms.

Funding

  • NIDDK Support